1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > PCR Technologies Global market - Forecast to 2022

PCR Technologies Global market - Forecast to 2022

  • May 2016
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 415 pages

Polymerase Chain Reaction (PCR) is a novel technique which doubles the amount of target DNA in every cycle. The PCR has three steps such as denaturation, annealing and extension, which are repeated in every cycle to achieve the product. PCR market has been divided as products, applications, techniques, end users and geography. PCR products market is further segmented into Instruments, reagents and consumables, software and services. In instruments there are traditional PCR’s and Real time PCR’s. Reagents and consumables are sub segmented into enzymes, dNTP’s, template DNA, primers and probes, buffers, master mixes, nuclease free water, consumable and others (tracking dye and wax beads). Software’s in the PCR market include Primer designers and sequence software’s, PCR data analysis software and others.

By application, the market is segmented into clinical diagnostics, industrial application, and others (Pathogen detection and dentistry). Clinical diagnostics are further divided into infectious and non infectious diseases. Infectious disease includes hepatitis B & C, tuberculosis, HIV and others. Non infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening and others. Industrial applications are divided into Agricultural, Environment, Applied testing, Animal husbandry, Biomedical research and other PCR industry applications. Applied testing includes forensic and food safety testing. Biomedical research includes DNA sequencing, genotyping, biomarker discovery, gene expression and genetic mapping, DNA cloning and others.

By Technique, the PCR market is segmented into standard PCR, real time PCR, reverse transcriptase PCR, digital PCR, assembly PCR, multiplex PCR, Hot start PCR and others. Others include nested PCR, Inverse PCR, Immune PCR, anchored PCR, RACE PCR, asymmetric PCR, universal PCR, ISSR PCR, allele specific PCR, ligation mediated PCR, touchdown PCR, solid phase PCR, methylation PCR, miniprimer PCR, nanoparticle assisted PCR, overlap extension PCR and In-situ PCR and long PCR. Based on the end- users PCR market is segmented into hospitals and laboratories, pharmaceuticals, CRO’s and biotech companies, academics and others (Blood banks).

Among the PCR technology products, Reagents & Consumables dominated the products market by occupying a largest share of XX%. At the same time, Reagents & Consumables market is the fastest growing segment from 2015 to 2022 with a CAGR of X% and is followed by services with a CAGR of XX%. In applications, the industry applications are the largest segment with XX% share and clinical diagnostics is expected to be the fastest growing segment from 2015 to 2022 with a CAGR of XX%. By end- users, Pharmaceuticals, CRO's and Biotech companies is the largest segment with a share of XX% and also, the fastest segment with a CAGR of XX% from 2015 to 2022. Geographical wise, North America is the largest market, with a share of XX% followed by Europe and Asia. The APAC region is the fastest growing region with a CAGR of XX% from 2015-2022 to reach $XX million.

The PCR technology market is expected to grow steadily at a CAGR of X% from 2015 to 2022. The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing, expiry of key players PCR patents, rising investments in the field of companion diagnostics, advent of digital PCR, increasing RT PCR based food safety testing, increasing affinity for automated high throughput and robotic systems and multiplexed analytical strategies for improving sensitivity and speed of PCR technology. However, high cost of commercial PCR assays in the clinical diagnostics, lack of awareness and requirement of skilled labour and development of alternative technologies are some of the factors restraining PCR Technologies market.

The PCR technologies global market is a highly competitive and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the Major players in the market are Abbott Laboratories, Inc., Inc. (U.S.), Agilent Technologies (U.S.), Becton, Dickinson and Company (U.S.), BioMerieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.K.) ), Hoffmann la Roche (Switzerland), Merck KGaA (Germany), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), Takara Bio, Inc.(Japan) and ThermoFisher Scientific, Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)

Table Of Contents

PCR Technologies Global market - Forecast to 2022

1 EXECUTIVE SUMMARY 29
2 INTRODUCTION 38
2.1 KEY TAKE AWAYS 38
2.2 REPORT DESCRIPTION 38
2.3 MARKETS COVERED 40
2.4 STAKEHOLDERS 44
2.5 RESEARCH METHODOLOGY 44
2.5.1 MARKET SIZE ESTIMATION 46
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 48
2.5.3 SECONDARY SOURCES 49
2.5.4 PRIMARY SOURCES 50
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 50
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 51
2.5.7 ASSUMPTIONS 51
3 MARKET ANALYSIS 53
3.1 INTRODUCTION 53
3.2 MARKET SEGMENTATION 54
3.3 FACTORS INFLUENCING MARKET 56
3.3.1 DRIVERS AND OPPORTUNITIES 56
3.3.1.1 Requirement of early detection of disease 56
3.3.1.2 Rising demand for PCR in genetic and molecular testing 57
3.3.1.3 Expiry of key players PCR patents 58
3.3.1.4 Rising investments in the field of companion diagnostics using pcr 58
3.3.1.5 Advent of digital PCR 59
3.3.1.6 Increasing RT-PCR based food safety testing 59
3.3.1.7 Increasing affinity for automated high throughput and robotic
systems in PCR 60
3.3.1.8 Multiplexed analytical strategies for improving sensitivity
and speed of PCR technology 61
3.3.1.9 Integration of technologies to be expected to accelerate the
speed of DNA analysis processes using PCR 61
3.3.2 RESTRAINTS AND THREATS 62
3.3.2.1 High cost of commercial PCR assays in clinical diagnostics 62
3.3.2.2 Lack of awareness and requirement of skilled labor 62
3.3.2.3 Development of alternate technologies 63
3.3.2.4 Stringent regulatory framework 63
3.3.3 PROBLEM AREAS 64
3.3.3.1 PCR Patent analysis 64
3.3.4 WINNING IMPERATIVE 65
3.3.4.1 PCR Portability 65
3.4 REGULATORY AFFAIRS 65
3.4.1 U.S. 65
3.4.2 EUROPE 66
3.4.3 CHINA 66
3.4.4 INDIA 66
3.4.5 JAPAN 67
3.5 PORTER'S FIVE FORCE ANALYSIS 68
3.5.1 THREAT OF NEW ENTRANTS 69
3.5.2 THREAT OF SUBSTITUTES 69
3.5.3 RIVALRY AMONG EXISTING COMPETITORS 69
3.5.4 BARGAINING POWER OF SUPPLIERS 70
3.5.5 BARGAINING POWER OF BUYERS 70
3.6 SUPPLY CHAIN ANALYSIS 71
3.7 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 73
3.8 PATENT TRENDS 76
4 GLOBAL PCR TECHNIQUES MARKET 78
4.1 INTRODUCTION 78
4.2 STANDARD PCR 80
4.3 REAL TIME PCR/QPCR 82
4.4 REVERSE TRANSCRIPTASE PCR 86
4.5 DIGITAL PCR 87
4.6 ASSEMBLY PCR 90
4.7 MULTIPLEX PCR 92
4.8 HOT START PCR 93
4.9 OTHERS 95
4.9.1 NESTED PCR 95
4.9.2 INVERSE PCR 96
4.9.3 IMMUNO PCR 96
4.9.4 LONG PCR 96
4.9.5 ANCHORED PCR 97
4.9.6 RAPID AMPLIFICATION OF CDNA ENDS (RACE) PCR 97
4.9.7 ASYMMETRIC PCR 98
4.9.8 UNIVERSAL PCR 98
4.9.9 INTER SEQUENCE-SPECIFIC PCR(ISSR-PCR) 98
4.9.10 ALLELE-SPECIFIC PCR 98
4.9.11 LIGATION MEDIATED PCR 98
4.9.12 TOUCHDOWN PCR 99
4.9.13 SOLID PHASE PCR 99
4.9.14 METHYLATION SPECIFIC PCR 99
4.9.15 MINIPRIMER PCR 100
4.9.16 NANOPARTICLE-ASSISTED PCR 100
4.9.17 OVERLAP EXTENSION PCR 100
4.9.18 IN SITU PCR 100
5 GLOBAL PCR PRODUCTS MARKET 102
5.1 INTRODUCTION 102
5.2 INSTRUMENTS 104
5.2.1 TRADITIONAL THERMOCYCLER 106
5.2.2 REAL TIME THERMOCYCLER 107
5.3 REAGENTS and CONSUMABLES 109
5.3.1 ENZYMES 112
5.3.2 DNTP'S 114
5.3.3 TEMPLATE DNA OR CONTROLS 116
5.3.4 PRIMERS AND PROBES 117
5.3.5 BUFFERS 119
5.3.6 MASTER MIXES 120
5.3.7 NUCLEASE FREE WATER 122
5.3.8 CONSUMABLES 123
5.3.9 OTHERS 125
5.4 SOFTWARE 127
5.4.1 PRIMER DESIGN AND SEQUENCING SOFTWARE 129
5.4.2 PCR DATA ANALYZER SOFTWARE 131
5.4.3 OTHERS 132
5.5 SERVICES 133
6 GLOBAL PCR APPLICATIONS MARKET 135
6.1 INTRODUCTION 135
6.2 CLINICAL DIAGNOSTICS 137
6.2.1 INFECTIOUS DISEASES 140
6.2.1.1 Hepatitis B and C testing 143
6.2.1.2 Tuberculosis diagnosis 145
6.2.1.3 HIV Diagnosis 147
6.2.1.4 Others 148
6.2.2 NON INFECTIOUS DISEASES 149
6.2.2.1 Prenatal diagnosis 152
6.2.2.2 Tissue typing 154
6.2.2.3 Cancer therapy 156
6.2.2.4 Genetic testing for hereditory diseases 158
6.2.2.5 Blood screening 160
6.2.2.6 Others 162
6.3 INDUSTRY APPLICATIONS 164
6.3.1 AGRICULTURAL BIOTECHNOLOGY 167
6.3.2 ENVIRONMENT 169
6.3.3 APPLIED TESTING 171
6.3.3.1 Forensics 173
6.3.3.2 Food safety testing 175
6.3.4 ANIMAL HUSBANDRY 177
6.3.5 BIOMEDICAL RESEARCH 179
6.3.5.1 DNA Sequencing 182
6.3.5.2 Genotyping 184
6.3.5.3 Biomarker discovery 185
6.3.5.4 Gene expression and genetic mapping 186
6.3.5.5 DNA Cloning 188
6.3.5.6 Other biomedical research applications 189
6.3.6 OTHER PCR INDUSTRIAL APPLICATIONS 191
6.4 OTHER PCR APPLICATIONS 192
6.4.1 PATHOGEN DETECTION 192
6.4.2 DENTISTRY 193
7 GLOBAL PCR END USERS MARKET 195
7.1 INTRODUCTION 195
7.2 HOSPITALS AND LABORATORIES 197
7.3 PHARMACEUTICALS, CRO'S AND BIOTECH COMPANIES 199
7.4 ACADEMICS 201
7.5 OTHERS 202
8 REGIONAL MARKET ANALYSIS 204
8.1 INTRODUCTION 204
8.2 NORTH AMERICA 206
8.2.1 U.S. 207
8.3 EUROPE 222
8.4 ASIA PACIFIC 238
8.5 REST OF THE WORLD 252
9 COMPANY DEVELOPMENTS 268
9.1 INTRODUCTION 268
9.1.1 NEW PRODUCT LAUNCHES AS MAJOR GROWTH STRATEGY OF PCR
MARKET PLAYERS 269
9.2 NEW PRODUCT LAUNCH 269
9.3 APPROVALS 276
9.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS and JOINT VENTURES 281
9.5 MERGERS AND ACQUISITION 284
9.6 OTHERS 287
10 MAJOR PLAYER PROFILES 288
10.1 ABBOTT LABORATORIES, INC. 288
10.1.1 OVERVIEW 288
10.1.2 FINANCIALS 289
10.1.3 PRODUCT PORTFOLIO 292
10.1.4 KEY DEVELOPMENTS 298
10.1.5 BUSINESS STRATEGY 300
10.1.6 SWOT ANALYSIS 301
10.2 AGILENT TECHNOLOGIES 302
10.2.1 OVERVIEW 302
10.2.2 FINANCIALS 303
10.2.3 PRODUCT PORTFOLIO 305
10.2.4 KEY DEVELOPMENTS 312
10.2.5 BUSINESS STRATEGY 313
10.2.6 SWOT ANALYSIS 314
10.3 BECTON DICKINSON AND COMPANY 315
10.3.1 OVERVIEW 315
10.3.2 FINANCIALS 316
10.3.3 PRODUCT PORTFOLIO 319
10.3.4 KEY DEVELOPMENTS 320
10.3.5 BUSINESS STRATEGY 322
10.3.6 SWOT ANALYSIS 323
10.4 BIOMERIEUX SA 324
10.4.1 OVERVIEW 324
10.4.2 FINANCIALS 325
10.4.3 PRODUCT PORTFOLIO 327
10.4.4 KEY DEVELOPMENTS 333
10.4.5 BUSINESS STRATEGY 335
10.4.6 SWOT ANALYSIS 336
10.5 BIO-RAD LABORATORIES 337
10.5.1 OVERVIEW 337
10.5.2 FINANCIALS 338
10.5.3 PRODUCT PORTFOLIO 340
10.5.4 KEY DEVELOPMENTS 342
10.5.5 BUSINESS STRATEGY 347
10.5.6 SWOT ANALYSIS 348
10.6 GE HEALTHCARE 349
10.6.1 OVERVIEW 349
10.6.2 FINANCIALS 350
10.6.3 PRODUCT PORTFOLIO 353
10.6.4 KEY DEVELOPMENTS 354
10.6.5 BUSINESS STRATEGY 355
10.6.6 SWOT ANALYSIS 356
10.7 HOFFMANN-LA ROCHE LTD. 357
10.7.1 OVERVIEW 357
10.7.2 FINANCIALS 358
10.7.3 PRODUCT PORTFOLIO 360
10.7.4 KEY DEVELOPMENTS 363
10.7.5 BUSINESS STRATEGY 365
10.7.6 SWOT ANALYSIS 366
10.8 MERCK KGAA 367
10.8.1 OVERVIEW 367
10.8.2 FINANCIALS 368
10.8.3 PRODUCT PORTFOLIO 370
10.8.4 KEY DEVELOPMENTS 373
10.8.5 BUSINESS STRATEGY 373
10.8.6 SWOT ANALYSIS 374
10.9 PROMEGA CORPORATION 375
10.9.1 OVERVIEW 375
10.9.2 FINANCIALS 376
10.9.3 PRODUCT PORTFOLIO 376
10.9.4 KEY DEVELOPMENTS 379
10.9.5 BUSINESS STRATEGY 380
10.9.6 SWOT ANALYSIS 381
10.10 QIAGEN N.V. 382
10.10.1 OVERVIEW 382
10.10.2 FINANCIALS 383
10.10.3 PRODUCT PORTFOLIO 385
10.10.4 KEY DEVELOPMENTS 389
10.10.5 BUSINESS STRATEGY 392
10.10.6 SWOT ANALYSIS 393
10.11 TAKARA BIO, INC. 394
10.11.1 OVERVIEW 394
10.11.2 FINANCIALS 395
10.11.3 PRODUCT PORTFOLIO 397
10.11.4 KEY DEVELOPMENTS 400
10.11.5 BUSINESS STRATEGY 401
10.11.6 SWOT ANALYSIS 402
10.12 THERMO FISHER SCIENTIFIC, INC. 403
10.12.1 OVERVIEW 403
10.12.2 FINANCIALS 404
10.12.3 PRODUCT PORTFOLIO 406
10.12.4 KEY DEVELOPMENTS 411
10.12.5 BUSINESS STRATEGY 413
10.12.6 SWOT ANALYSIS 414

LIST OF FIGURES


FIGURE 1 GLOBAL PCR MARKET SHARE AND REVENUE, BY REGION,
(2014-2022) ($MN) 32
FIGURE 2 RESEARCH METHODOLOGY: POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET 45
FIGURE 3 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 46
FIGURE 4 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: FORECASTING MODEL 47
FIGURE 5 POLYMERASE CHAIN REACTION (PCR) GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION 48
FIGURE 6 PCR MARKET: MARKET SEGMENTATION 54
FIGURE 7 MARKET DYNAMICS 56
FIGURE 8 PCR MARKET: PORTER'S ANALYSIS 68
FIGURE 9 PCR MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 10 GLOBAL PCR MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%) 73
FIGURE 11 PCR TECHNOLOGIES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016) 76
FIGURE 12 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY TECHNIQUE,
(2015 V'S 2022), ($MN) 79
FIGURE 13 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
(2015 V'S 2022), ($MN) 103
FIGURE 14 GLOBAL PCR REAGENTS AND CONSUMABLES MARKET SHARE (2015), (%) 110
FIGURE 15 GLOBAL PCR SOFTWARE MARKET SHARE (2015 VS 2022), (%) 128
FIGURE 16 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, (2014-2022) ($MN) 136
FIGURE 17 GLOBAL PCR CLINICAL DIAGNOSTIC APPLICATION MARKET SIZE, BY TYPE, (2014-2022) ($MN) 139
FIGURE 18 GLOBAL PCR CLINICAL DIAGNOSTIC INFECTIOUS MARKET SHARE BY TYPE, (2015 V'S 2022) (%) 141
FIGURE 19 GLOBAL PCR CLINICAL DIAGNOSTIC NON INFECTIOUS MARKET SIZE, BY TYPE, (2015) ($MN) 150
FIGURE 20 GLOBAL PCR INDUSTRIAL APPLICATION MARKET SHARE, (2015) (%) 165
FIGURE 21 GLOBAL PCR BIOMEDICAL RESEARCH APPLICATION MARKET SIZE, (2015 V'S 2022) ($MN) 180
FIGURE 22 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY END USERS,
(2014-2022) ($MN) 196
FIGURE 23 GLOBAL PCR TECHNOLOGIES MARKET SIZE, BY REGION, (2014-2022) ($MN) 205
FIGURE 24 NORTH AMERICA PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION and END-USER,
(2015 V'S 2022) ($MN) 209
FIGURE 25 EUROPEAN PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION and END-USER, (2015 V'S 2022) ($MN) 224
FIGURE 26 ASIA PACIFIC PCR TECHNOLOGY MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION and END-USER, (2015 V'S 2022) ($MN) 239
FIGURE 27 ROW PCR TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, PRODUCT, APPLICATION and END-USER, (2015 V'S 2022) ($MN) 254
FIGURE 28 KEY GROWTH STRATEGIES (2014-2016) 268
FIGURE 29 SWOT: ABBOTT LABORATORIES, INC. 301
FIGURE 30 SWOT: AGILENT TECHNOLOGIES 314
FIGURE 31 SWOT: BECTON DICKINSON AND COMPANY 323
FIGURE 32 SWOT: BIOMERIEUX 336
FIGURE 33 SWOT: BIO-RAD LABORATORIES 348
FIGURE 34 SWOT: GE HEALTHCARE 356
FIGURE 35 SWOT: HOFFMANN-LA ROCHE 366
FIGURE 36 SWOT: MERCK KGAA 374
FIGURE 37 SWOT: PROMEGA CORPORATION 381
FIGURE 38 SWOT: QIAGEN N.V. 393
FIGURE 39 SWOT: TAKARA BIO INC 402
FIGURE 40 SWOT: THERMO FISHER SCIENTIFIC 414

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Agrigenomics Market by Application, Sequencer Type, Objective, and Region - Global Forecast to 2021

Agrigenomics Market by Application, Sequencer Type, Objective, and Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

“The agrigenomics market is projected to grow at a CAGR of 7.8%, in terms of value” The agrigenomics market is projected to reach USD 13.56 billion by 2021. Rising funds toward agrigenomics research ...

US Next-generation Sequencing Services Market

US Next-generation Sequencing Services Market

  • $ 4950
  • Industry report
  • September 2016
  • by Frost & Sullivan

$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation o ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in Denmark and Brazil

  • November 2016
    9 pages
  • Genetic  

  • Denmark  

    Brazil  

View report >

Global Nanomedicine Industry - Forecast

  • November 2016
    23 pages
  • Nanomedicine  

    Personal Genomi...  

    Gene Therapy  

  • United States  

    World  

    Japan  

View report >

Genome Sequencing Industry in the UK

  • November 2016
    29 pages
  • Genome Sequenci...  

    Infectious Dise...  

  • United Kingdom  

    United States  

View report >

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.